Neural precursors persist throughout life in the rodent forebrain subventricular zone (SVZ) and hippocampal dentate gyrus. The regulation of persistent neural stem cells is poorly understood, in part because of the lack of neural progenitor markers. The Sox B1 subfamily of HMG-box transcription factors (Sox1-3) is expressed by precursors in the embryonic nervous system, where these factors maintain neural progenitors in an undifferentiated state while suppressing neuronal differentiation. Sox2 expression persists in germinative zones of the adult rodent brain, but Sox3 expression in the postnatal brain remains largely unexplored. Here we examine Sox3 expression in the neonatal and adult mouse brain to gain insight into its potential involvement in regulating persistent neural stem cells and neurogenesis. We also investigate Sox3 expression during expansion and neural differentiation of postnatal mouse SVZ neural stem cell and human embryonic stem cell (hESC) cultures. We find that Sox3 is expressed transiently by proliferating and differentiating neural progenitors in the SVZ-olfactory bulb pathway and dentate gyrus. Sox3 immunoreactivity also persists in specific postmitotic neuronal populations. In vitro, high Sox3 protein expression levels in undifferentiated, SVZ-derived neurospheres decline markedly with differentiation. Sox3 immunoreactivity in hESCs appears upon differentiation to neural progenitors and then decreases as cells differentiate further into neurons. These findings suggest that Sox3 labels specific stages of hESC-derived and murine neonatal and adult neural progenitors and are consistent with a role for Sox3 in neural stem cell maintenance. Persistent Sox3 expression in some mature neuronal populations suggests additional undefined roles for Sox3 in neuronal function.
SVZ-olfactory bulb pathway express immature neuronal markers such as doublecortin (DCx), polysialylated neural cell adhesion molecule (PSA-NCAM), and neuron-specific ␤-tubulin (Peretto et al., 1997; Gleeson et al., 1999) . Recent evidence indicates that adult-generated olfactory bulb and dentate gyrus neurons are functionally incorporated into existing neural circuits (Carlen et al., 2002; van Praag et al., 2002; Belluzzi et al., 2003) . Studies suggest that adult neurogenesis is important for hippocampusdependent learning and olfactory discrimination (Corotto et al., 1994; Kempermann et al., 1997; Gould et al., 1999; Gheusi et al., 2000; Shors et al., 2001; Rochefort et al., 2002) .
Neonatal and adult neural progenitors also can be isolated from the SVZ and SGZ and cultured to form neurospheres. The progenitors self-renew in vitro in the presence of mitogens such as epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF; Reynolds and Weiss, 1992; Gritti et al., 1996; Seaberg and van der Kooy, 2002) . Mitogen withdrawal induces neurophere-derived cells to differentiate into neurons, astrocytes, and oligodendrocytes (Reynolds and Weiss, 1992) . Several classes of molecules, including growth factors and neuromodulators, as well as other cell types, such as astrocytes, modulate adult neurogenesis in vivo or in vitro (Craig et al., 1996; Kuhn et al., 1997; Zigova et al., 1998; Wagner et al., 1999; Song et al., 2002) . Adult neural stem cells in rodent SVZ and dentate gyrus have been identified in vivo as glial fibrillary acidic protein (GFAP)-expressing radial glia-like cells (Doetsch et al., 1999; Seri et al., 2001) . Unlike the case for hematopoietic stem cells, however, markers to identify neural stem cells specifically in situ remain unidentified.
SRY-related high mobility group (HMG)-box proteins are key regulators for cell fate decisions. They act either as classical transcription factors or as architectural components of chromatin (Pevny and Lovell-Badge, 1997) . Among them, the intronless Sox B1 subfamily (Sox1-3), which shares a conserved region in the C-terminal in addition to the HMG box, is expressed by the neuroepithelium in the embryonic nervous system (Collignon et al., 1996) . Prior to its expression in the developing nervous system, Sox2 is expressed as early as in the inner cell mass stage, and Sox2 and Sox3 also are expressed in the primitive ectoderm and epiblast (Collignon et al., 1996; Wood and Episkopou, 1999) . In adult mouse brains, Sox2 expression is detected in the SVZ and RMS (Zappone et al., 2000) . Experiments with chick in ovo eletroporation show that the neurogenic specification of proneural proteins depends on the inhibition of Sox1-3 expression (Bylund et al., 2003; Graham et al., 2003) . Sox2-deficient mice also show reduced adult neurogenesis in the SVZ and SGZ (Ferri et al., 2004) . These findings suggest that Sox1-3 may maintain neural progenitor cells in an undifferentiated state and suppress neuronal differentiation (Pevny and Rao, 2003) .
Sox3 is an X-linked gene (Stevanovic et al., 1993) , and mutations in humans cause a syndrome of mental retardation with growth hormone deficiency (Laumonnier et al., 2002) . Knockout studies in mice show that Sox3 is involved in the formation of the hypothalamic-pituitary axis (Rizzoti et al., 2004) . Consistently with a role in neural development, Sox3 is up-regulated transiently during retinoic acid-induced neural differentiation of NT2 embryonic carcinoma cells (Stevanovic, 2003) . Expression of Sox3 mRNA has been detected in the perinatal forebrain SVZ (Karsten et al., 2003) ; however, the expression pattern, cellular identities, and function of Sox3 in the neonatal or adult mammalian brain are unexplored. Here we use an anti-Sox3 antibody to detect the spatiotemporal expression patterns of Sox3 protein in the neonatal and adult mouse brain and in neural stem cell cultures derived from postnatal mouse SVZ or human embryonic stem cells (hESCs).
MATERIALS AND METHODS

Neurosphere cultures
Postnatal day 15 (P15) CD-1 albino mice (Charles River) were anesthetized with CO 2 and their brains removed. Brains were cut into 2-mm-thick coronal blocks, and the lateral SVZ tissue was dissected, minced into small pieces, and dissociated with trypsin. Approximately 3-8 ϫ 10 4 SVZ cells (pooled from three or four brains) per 60-mm dish were cultured in Dulbecco's modified Eagle's medium (DMEM)/F12 nutrient (1:1; Gibco, Grand Island, NY) containing 20 ng/ml epidermal growth factor (EGF; Sigma, St. Louis, MO) and 10 ng/ml basic fibroblast growth factor (bFGF; Sigma). Primary NS were cultured for 6 -7 days in vitro (DIV), mechanically dissociated and plated for differentiation at 1 ϫ 10 5 cells/well in 24-well plates (Corning-Costar, Cambridge, MA) coated with polyornithine (Sigma).
hESC cultures
Differentiation experiments were conducted with the H1 hESC line (Thomson et al., 1998) obtained from WiCell Inc. (Madison, WI). Undifferentiated cells were maintained as described previously (Thomson et al., 1998) . hESCs were grown on feeder cell layers of irradiated mouse embryonic fibroblasts (MEFs), which were isolated and plated by using standard tissue culture techniques. Neuronal differentiation was initiated under maintenance culture conditions. hESC colonies were grown to high density, leading to the development of embryoid bodies (EBs). EBs were then passaged onto gelatin-coated plates without feeder cells. The cells were cultured for 10 days in a medium formulation containing DMEM/F12, 20% fetal bovine serum, L-glutamine, and nonessential amino acids (to promote differentiation) and then fixed with 4% PFA.
In vivo bromodeoxyuridine (BrdU) labeling and tissue processing nally at 40 m thickness. To identify differentiating and postmitotic, adult-generated cells, some adult mice were killed 4 (n ϭ 4) or 14 (n ϭ 4) days after a single 100 mg/kg i.p. BrdU injection and the brains processed as described above.
Immunocytochemistry
Cell cultures were fixed with 4% PFA for 30 minutes and rinsed three times with PBS. For immunofluorescence labeling, sections or cells were rinsed in Tris-buffered saline (TBS; pH 7.4) and incubated in blocking buffer for 1 hour prior to incubation with the following primary antibodies (see Table 1 ) alone or in species-appropriate combinations for 48 hours at 4°C: rabbit anti-Sox3 (Zhang et al., 2003) , rabbit anti-Sox2, mouse IgM anti-PSA-NCAM (5A5 clone), mouse anti-GFAP, mouse anti-calretinin, mouse anti-NeuN, or mouse anti-class III ␤-tubulin (TuJ1 clone). After three TBS washes, sections or cells were incubated with Alexa Fluor 594-or 488-conjugated goat anti-rabbit and anti-mouse IgG secondary antibody (1: 200; Molecular Probes, Eugene, OR) or with fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgM secondary antibodies (1:200; Jackson Immunoresearch, West Grove, PA) at room temperature for 2 hours, washed three times with TBS, mounted on slides, and coverslipped with antifade medium (Pro-Long; Molecular Probes). For BrdU immunohistochemistry, sections were incubated with 2 N HCl at 37°C for 30 minutes to denature DNA, then neutralized with 0.1 M sodium borate (pH 8.5) for 10 minutes. After TBS washes, sections were incubated with rat antiBrdU (1:50; Serotec) and rabbit anti-Sox3 antibodies at 4°C for 48 hours and then processed as described above with Alexa 594-conjugated goat anti-rat IgG and Alexa 488 goat anti-rabbit secondary antibodies (1:200). In double-labeling experiments, some sections were processed with one of the primary antibodies omitted as a control, and nonspecific double labeling was not observed. For BrdU labeling, the denaturing steps were not performed on some sections as a control, and no nuclear staining was seen. For all other antibodies, which were used as markers, accurate subcellular and tissue expression patterns were confirmed based on prior reports (cited in the footnotes to Table 1 ). For Sox3 diaminobenzidine (DAB) staining, sections were processed as follows: rinses with Tris buffer and then Tris buffer with Triton X-100/bovine serum albumin (BSA), blocking with 10% normal goat serum in Tris buffer with Triton X-100/BSA for 1 hour prior, and then incubation with anti-Sox3 antibody at 4°C overnight. After Tris buffer washes, sections were incubated with biotinylated goat anti-rabbit IgG (1:200; Jackson Immunoresearch) and then avidin-biotin peroxidase (ABC) complex (Vector, Burlingame, CA). For color reaction, sections were then incubated with stable DAB (Invitrogen, Calsbad, CA). Images were captured with a Leica DSM-IRB epifluorescence microscope and Spot-RT digital camera or, for double-labeling, as z-series thin optical sections with a Zeiss LSM-510 confocal microscope. Digital images were imported into Adobe Photoshop v.6.0 (Adobe Systems, Mountain View, CA) for color merging. Contrast and brightness were adjusted slightly to keep background intensity levels comparable among the animals of different ages.
Western blots
The olfactory bulbs and hippocampi of adult CD-1 mice and whole brains of adult zebrafish were dissected out and homogenized, and protein was extracted. Frozen adult human hippocampal tissue was obtained from the University of Miami Brain and Tissue Bank with University of Michigan Institutional Review Board approval. Protein extracts were prepared in sample buffer (50 mM Tris-HCl, 1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 g/ml aprotinin, leupeptin, and pepstatin). The extracts were subjected to SDS-PAGE and then Western blot analysis to detect Sox3 and Sox2 proteins.
RESULTS
Specificity of Sox3 antibody
We first sought to determine whether an anti-Sox3 antibody developed using the C-terminal 20 amino acids of Xenopus Sox3 (Zhang et al., 2003) and cross-reactive with zebrafish Sox3 (Zhang et al., 2004) would recognize mouse 1 Western blot reveals a band of about 50 kD with this antibody; it is highly expressed in immature neurons (Doetsch et al., 1997) . 2 The antibody also recognizes BrdU attached to a protein carrier and free BrdU. It does not cross-react with thymidine but does react weakly with chlorodeoxyuridine. 3 The antibody recognizes a 30-kD band on immunoblot. It is expressed by immature dentate granule cells (Brandt et al., 2003) and other neuronal subtypes. 4 A 52-kD band is found on Western blot with this antibody. GFAP is expressed by radial glia-like stem cells in SVZ and dentate gyrus (Doetsch et al., 1999; Seri et al., 2001 ) and astrocytic tube-forming cells in the RMS (Peretto et al. 1997) . 5 Recognizes two to three bands in the 46 -48-kD range and possibly another band of approximately 66 kD by Western blot. The antigen is expressed by mature neurons in adult mouse dentate gyrus (Brandt et al., 2003) . 6 Recognizes a 200-kD band on Western blot. Nestin is expressed by radial glia-like neural progenitors in adult mouse SVZ and dentate gyrus (Seri et al., 2001 ). 7 Antibody yields bands ranging from about 180 to 200 kD (due to variable numbers of PSA residues). PSA-NCAM is expressed by immature neurons in postnatal germinative zones (Gheusi et al., 2000) . 8 The peptide sequence is SSSPPVVTSSSHSRAPC. The antibody recognizes a 34-kD band in nuclear extracts not observed in cytosolic extracts on Western blots. Sox2 is expressed in neural progenitor cells (Komitova and Eriksson, 2004) .
The Journal of Comparative Neurology. DOI 10.1002/cne and human Sox3. Western blotting therefore was used to test the specificity of the antibody. The anti-Sox3 antibody was applied to protein extracted from mouse olfactory bulb, human hippocampus, and zebrafish whole brain. It recognized protein bands of 38, 45, and 34 kD, respectively, which are the appropriate sizes of Sox3 protein for each species (Fig. 1 ). To determine whether the anti-Sox3 antibody cross-reacted with Sox2 protein, we examined whether the Sox3 antibody recognized a 34-kD band, the expected size of mouse or human Sox2 protein (Stevanovic et al., 1993 (Stevanovic et al., , 1994 Collignon et al., 1996; Malas et al., 1997) . When applied to the mouse olfactory bulb sample, the anti-Sox3 antibody did not yield a 34-kD band, although a rabbit anti-mouse Sox2 antibody did (data not shown). However, a band of this size was found with the anti-Sox3 antibody in the human hippocampal tissue sample. These data suggest that the anti-Sox3 antibody recognizes Sox3, and not Sox2, in mouse. Although the antibody may also recognize Sox2 in human tissue by Western blot, the data on hESC Sox2 and Sox3 expression described below argue against the possibility that the antibody recognizes human Sox2 by immunocytochemistry.
Ontogeny of Sox3 expression in postnatal mouse brain
To map the spatiotemporal expression pattern of Sox3 protein in postnatal mouse brain, we performed immunohistochemistry on P2, P7, P14, and adult brain sections with the anti-Sox3 antibody. Sox3 expression was detected in both persistent neurogenic brain regions, the SVZ and dentate gyrus, from P2 to adulthood ( Fig. 2A ,B,E,F,I,J). Sox3 immunoreactivity also appeared in the RMS (Fig.  2D ,H) and the olfactory bulb subependymal, granular, and Fig. 1 . Western blot of Sox3 protein expression in zebrafish brain, mouse hippocampal formation and olfactory bulb, and human hippocampus. The anti-Sox3 antibody raised to a peptide of Xenopus Sox3 recognizes a 34-kD band in whole zebrafish brain, a 38-kD band in mouse olfactory bulb and hippocampus, and a 45-kD band in human hippocampus (arrows). The antibody probably also binds to human Sox2 protein, because it yields an additional 34-kD band (arrowhead) with human hippocampal protein extract. Zf, zebrafish; Mh, mouse hippocampus; Mob, mouse olfactory bulb; Hh, human hippocampus. (Fig. 2C,G) . Sox3 was expressed not only in the SGZ but also in the hilus on P2 (Fig. 2B) . With increasing age from P7 to adulthood, dentate gyrus Sox3 expression became more restricted to the SGZ (Fig. 2F,J) . In addition to neurogenic regions of the mature brain, Sox3 immunoreactivity was detected in the adult mouse olfactory tubercle, dorsolateral septum, cerebellar Purkinje cell layer, lateral habenular nucleus, and ventromedial part of the hypothalamus (Fig. 2H ,K,L, Table 2 ). More scattered Sox 3 expression appeared in the cortex and striatum of adults (Fig. 2I , and data not shown). No Sox3 immunoreactivity appeared in the corpus callosum or other fiber tracts.
Subsets of Sox3-expressing cells actively proliferate in postnatal mouse brain
To examine whether Sox3-positive cells in postnatal neurogenic brain regions proliferate, neonatal (P2, 7, and 14) and adult mice received a single pulse BrdU injection, and 2 hours later the patterns of BrdU and Sox3 immunoreactivities were examined. The SVZ and RMS were analyzed first. Despite the presence of many dividing cells and intense Sox3 expression in the SVZ from P2 to P14, minimal overlap existed between these populations; few double-labeled cells were found in the dorsolateral and ventral SVZ (Fig. 3A ,B,D-EЈ). Sox3-positive cells were located closer to the ventricle than BrdU-labeled cells in both the SVZ and the RMS of neonates (Fig. 3A ,B,D-EЈ,G). In adults, most of the BrdU-positive cells in the SVZ (90%) and nearly all in the RMS coexpressed Sox3 (Fig.  3C,F ,FЈ,H-HЈЈ). We next examined proliferating cells in the dentate gyrus. In the P2 dentate, BrdU-labeled cells appeared mainly in the SGZ, whereas Sox3-immunoreactive cells were scattered in the hilus (Fig. 3I) . The overlap of these two populations progressively increased with age. At P7, fewer than 3% of SGZ BrdUpositive cells were Sox3-positive. By P14, 31% of BrdUpositive cells in the SGZ coexpressed Sox3 (Fig. 3J) , and Sox3-labeled cells were closer to the SGZ than at younger ages. In adults, most of the dentate Sox3-positive cells were found in the SGZ; all of the SGZ BrdU-labeled cells expressed Sox3 (Fig. 3K) . Many of the adult SGZ Sox3-immunostained cells that were BrdU negative likely were proliferative cells that were not in S phase 2 hours earlier when BrdU was injected. These data suggest that Sox3 is expressed by relatively quiescent, neural stem/progenitor cells in the neonatal forebrain, and that with age the progenitors proliferate more actively and assume a slightly more differentiated state.
The pattern of Sox3 expression during neuronal differentiation in the adult was next studied. Adult mice received BrdU and were killed 2 hours, 4 days, or 14 days later. Two hours after a single pulse BrdU injection, nearly all of the BrdU-positive cells in the RMS, SVZ, and SGZ expressed Sox3 (Figs. 3C,FЈ,H,K, 4A,D-DЈЈ). By 4 days after BrdU administration, only about 7% of the BrdU-positive cells in the SGZ still expressed Sox3 (Fig. 4B) ; the percentage decreased further to 4% at 14 days (Fig. 4C ,E-EЈЈ). We next examined the SVZolfactory bulb pathway. At 2 hours after BrdU labeling, many labeled cells were present in the SVZ, and few BrdU-immunoreactive cells appeared in the olfactory bulb. As described above, nearly all BrdU-positive cells expressed Sox3. The BrdU labeling pattern was reversed by 4 days, with many BrdU-positive cells found in the olfactory bulb subependymal zone, and some remaining in the SVZ. Most of the BrdU-labeled cells in both regions continued to be Sox3-positive (data not shown). By 14 days after BrdU injections, many BrdUlabeled cells had migrated to the granular cell layer of the olfactory bulb, one of the final destinations of SVZ neuroblasts, and appeared to be Sox3 negative (data not shown). BrdU-positive cells remaining in the SVZ were located mainly in the ventral portion, and nearly all coexpressed Sox3 (data not shown). These results suggest that adult-generated neural progenitors in both neurogenic regions down-regulate Sox3 expression after they exit the cell cycle and begin to differentiate.
Phenotypes of Sox3-immunoreactive cells in the adult SVZ-olfactory bulb pathway
To determine the cellular identity of Sox3-positive cells in the adult mouse olfactory bulb, RMS, and SVZ, we performed immunofluorescent double labeling for Sox3 and cell-type-specific markers. Immunostaining was analyzed by confocal microscopy using z-series with thin optical sections. In the SVZ, about 56% of Sox3-positive cells in the SVZ expressed the immature neuronal marker ␤-tubulin (Fig. 5A) , and a similar proportion coexpressed another neuroblast marker, PSA-NCAM (Fig. 5B) . Approximately 28% of Sox3-immunoreactive cells coexpressed the neural stem cell and astroglial marker glial fibrillary acidic protein (GFAP); most of the double-labeled cells were surrounded by GFAP ϩ /Sox3 -cells (Fig. 5C ). Some Sox3-immunoreactive cells in the SVZ also immunolabeled for the neural progenitor cell marker nestin (data not shown). In the RMS, most Sox3-positive cells coexpressed ␤-tubulin and were surrounded by GFAP- 
positive cells (Fig. 5D,E) . In the subependymal zone of the olfactory bulb, 38% of Sox3-immunoreactive cells were doubly labeled for ␤-tubulin (Fig. 5G) , and some were also PSA-NCAM-positive (Fig. 5F ). Almost 30% of Sox3-labeled cells in the granular layer were immunoreactive for the mature neuronal marker NeuN (Fig. 5H ). These findings indicate that Sox3 is transiently expressed by SVZ neural stem cells and their undifferentiated progeny in the SVZ-olfactory bulb pathway, and then expression is turned off as the cells differentiate into olfactory granular layer neurons.
Sox3 expression during adult dentate granule cell neurogenesis
We next examined the phenotypes of Sox3-positive cells in the adult mouse SGZ with double-label immunofluorescence for Sox3 and cell-type-specific markers. Subpopulations of Sox3-positive cells in the SGZ frequently expressed neuroblast markers, such as PSA-NCAM (Fig.  6A,B) , ␤-tubulin (33%, Fig. 6D-G) , and calretinin (22%, Fig. 6C ). By contrast, relatively few expressed the more mature neuronal marker NeuN (9%, Fig. 6H-J) . Nearly half of the Sox3-immunoreactive cells coexpressed GFAP (48%, Fig. 6K-M) . Many of these Sox3/GFAP doublelabeled cells appeared to have a radial glial-like morphology, suggesting that they were SGZ progenitor cells (Seri et al., 2001 (Seri et al., , 2004 . Consistent with this idea, we found similar cells with radial glial morphology that coexpressed Sox3 and nestin in the dentate gyrus (data not shown). These results, combined with the pulse-chase BrdU labeling data described above (Fig. 4) , provide strong evidence that neural progenitor cells and differentiating neuroblasts in the dentate SGZ express Sox3 and that this expression declines as the cells differentiate into dentate granule neurons. 
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Because other Sox proteins exist in the SoxB1 subfamily, we also analyzed the locations and phenotypes of Sox2-immunoreactive cells in the adult mouse SVZ and dentate gyrus by using antibodies for Sox2 (Ferri et al., 2004; Komitova and Eriksson, 2004 ) and cell-typespecific markers. We found that the vast majority of Sox2-positive cells in the dentate gyrus were located in the SGZ and coexpressed GFAP (79% , Fig. 6N) ; smaller proportions of Sox2-immunoreactive cells in the SGZ expressed the neuroblast markers PSA-NCAM (31%), neuron-specific ␤-tubulin (21%), or calretinin (23%, Fig.  6O , and data not shown). No Sox2-labeled cells coexpressed NeuN (data not shown). In the SVZ, most Sox2-positive cells showed GFAP immunoreactivity, and a smaller number coexpressed ␤-tubulin (data not shown). These findings suggest that, like Sox3, Sox2 is expressed by neural progenitors and immature neurons and is rapidly down-regulated with differentiation. In addition, Sox2 expression patterns are shifted to more immature cells than Sox3, with greater percentages of GFAP-labeled progenitor-like cells and fewer differentiated neurons expressing Sox2.
Sox3 expression in neural stem cells derived from postnatal mouse SVZ and hESCs
To examine the temporal pattern of Sox3 expression during neuronal differentiation, we took advantage of well-defined in vitro methods for culturing neural stem cells from postnatal mouse SVZ and hESCs (Reynolds and Weiss, 1992; Thomson et al., 1998; Zhang et al., 2001 ). SVZ cells from P15 mouse were expanded as neurospheres in the presence of bFGF and EGF. Cultures were fixed without differentiation and labeled with antibodies against Sox3 and the neural progenitor marker nestin. Most cells in the undifferentiated neurospheres expressed both Sox3 and nestin (Fig. 7A-C) . In subsequent experi- ments, we dissociated the primary neurospheres and differentiated them for 4 hours, 2 days, or 8 days to determine the temporal pattern of Sox3 expression during neural differentiation. Cultures were fixed and immunostained for Sox3 and cell-type-specific markers. After only a 4-hour differentiation to let cells adhere to the tissue culture dish, nearly all the cells expressed Sox3, and no neurons or glia were present (Fig. 7D , and data not shown). Cultures differentiated for 2 days showed slightly decreased Sox3 immunoreactivity, and a few ␤-tubulinimmunoreactive neurons and GFAP-immunoreactive astrocytes were detected (Fig. 7E,F) . Few Sox3-positive cells coexpressed GFAP (Fig. 7E) , and none coexpressed ␤-tubulin (Fig. 7F) . After 8 days, Sox3 expression diminished markedly and more astrocytes and neurons appeared. Some of the astrocytes expressed very low levels of Sox3 (Fig. 7G) , but no Sox3/␤-tubulin doubled-labeled cells were found (Fig. 7H) .
We next explored neurospheres derived from hESCs. The NIH-approved H-1 hESC clone was cultured on irradiated MEFS and then differentiated into a neural lineage. Prior to differentiation, hESCs showed immunoreactivity for Oct3/4 and Sox2, but not Sox3 (data not shown). After neural differentiation, Sox3 immunoreactivity appeared in many cells located more centrally within the neurospheres, whereas ␤-tubulin-positive neurons were found more peripherally, and few expressed Sox3 (Fig. 7I , and data not shown). Consistent with the in vivo data described above, these findings suggest that postnatal mouse SVZ and hESC-derived neural progenitors express Sox3 and that both cell types turn off expression as they undergo differentiation into neurons or astrocytes.
DISCUSSION
Our results indicate that Sox3 protein expression persists in the neonatal and adult mouse forebrain SVZ, RMS, olfactory bulb, and SGZ. A subset of Sox3-positive cells in the SVZ and SGZ actively proliferates in the neonate, and the proportion increases markedly in adulthood. Many Sox3-immunoreactive cells in the adult SVZ and SGZ appear to be radial glia-like, GFAP-positive stem/ progenitor cells, whereas others coexpress immature neuronal markers consistent with transit-amplifying progenitor or neuroblast phenotypes. In mouse SVZ or hESCderived neurospheres, most cells initially express Sox3 and then down-regulate expression during differentiation. This constellation of findings supports a role for Sox3 in mammalian forebrain neural stem/progenitor cell function throughout life. The lower level of Sox3 expression seen in specific nonneurogenic regions of the adult mouse brain suggests that this protein also maintains nondevelopmental functions, the nature of which remains to be determined.
Anti-Sox3 antibody recognizes Sox3 in neural progenitor cells
Interpretation of immunohistochemical data largely depends on antibody specificity. Although our anti-Sox3 antibody was raised in Xenopus, Western blots suggest that it recognizes a band of the appropriate size for Sox3 in zebrafish, mouse, and human brain. Although the antibody yields a second band when reacted with human brain that is closest to human Sox2 in size, albeit slightly smaller, several pieces of evidence suggest that the antibody does not detect Sox2 by immunohistochemistry. First, undifferentiated hESCs are known to express Sox2 and not Sox3 (Stevanovic, 2003; Ginis et al., 2004; Boyer et al., 2005; Stromberg and Parent, unpublished results) , whereas both proteins are expressed after neural differentiation. We confirmed these findings by immunocytochemistry with our Sox3 and a commercial Sox2 antibody. Second, the immunoreactivity pattern of Sox3 and Sox2 in mouse, although similar, did not completely overlap. In the adult mouse dentate gyrus, for example, no NeuNpositive cells expressed Sox2, but nearly 10% coexpressed NeuN and Sox3. The possibility that the antibody recognizes Sox1 in addition to Sox3 is unlikely based on the Western blot data but cannot be excluded entirely at present; obtaining Sox3 null mouse tissue for immunohistochemistry will eventually clarify this issue.
The Sox B1 subfamily (Sox1-3) proteins are expressed by the embryonic neuroepithelium (Collignon et al., 1996) . In terms of later expression, recent studies indicate that almost all newly divided cells in the SVZ and SGZ express Sox2, and some of these Sox2-positive cells coexpress GFAP and display a radial glia-like morphology (Ferri et al., 2004; Komitova and Eriksson, 2004) . Some weakly labeled Sox2-immunoreactive cells in the RMS also are immunoreactive for PSA-NCAM (Ferri et al., 2004) . We found similar Sox2 expression patterns in the adult, and Sox3 immunoreactivity appeared in an overlapping but not identical pattern. Two hours after a BrdU pulse, almost all of the BrdU-labeled cells in the adult SVZ and SGZ expressed Sox3. Type B cells in the SVZ and radial glia-like cells in the SGZ that express GFAP are considered to be neural stem-like cells (Doetsch et al., 1999; Seri et al., 2001 ). In the SGZ, nearly half of the Sox3-immunoreactive cells coexpressed GFAP and displayed a radial glia-like morphology, as did many in the SVZ. A subpopulation of Sox3-positive cells in the SVZ and SGZ also expressed the neuroblast marker PSA-NCAM or ␤-tubulin. A few NeuN-positive cells in the OB and dentate gyrus still maintained Sox3 expression, but Sox3 immunoreactivity was absent in most differentiated neurons in these regions. Taken together, these findings suggest that Sox3 is expressed mainly by primary progenitors, transit-amplifying cells, and neuroblasts.
Further support for the neural progenitor cell nature and temporal pattern of Sox3 expression derives from our in vitro studies. Most cells in undifferentiated mouse SVZ neurospheres initially express Sox3 and then downregulate expression during differentiation. Similarly, most neural progenitors but few differentiating neurons derived from hESCs show Sox3 immunoreactivity. These data therefore provide strong evidence that Sox3 is ex- pressed by neural progenitor cells and transiently by their newly generated neuronal progeny in mice and humans.
Ontogeny of Sox3 in postnatal SVZ and SGZ
In the mouse embryo, Sox3 is expressed in the primitive ectoderm, epiblast, and neuroepithelium (Collignon et al., 1996; Wood and Episkopou, 1999) , but little is known about its postnatal expression. We find that Sox3 is present in postnatal neurogenic regions as early as P2 and persists into adulthood. Sox3 expression in the neonatal dentate gyrus and SVZ shows much less overlap with dividing (BrdU-labeled) cells 2 hours after a single pulse BrdU injection than in the adult. In the neonatal SVZ and RMS, Sox3 is expressed closer to the ventricle than the BrdU-positive cells. BrdU-and Sox3-postive cells in the P2 dentate gyrus appear in largely nonoverlapping populations scattered in the hilus, and over time Sox3 expression becomes established in the SGZ tertiary matrix (Altman and Bayer, 1990a,b; Li and Pleasure, 2005) .
The pattern of Sox3 immunoreactivity relative to proliferating cells at early postnatal ages, with Sox3 closer to the ventricle in the ventral SVZ and scattered in the dentate hilus, suggests that this marker labels a relatively quiescent progenitor population. This result also fits with reports that primary neural progenitors in the adult appear to be more proliferative than at younger ages, especially in the dentate gyrus (Doetsch et al., 1999; Seri et al., 2001) . The most plausible explanation for this finding is that Sox3 is expressed in transit-amplifying cells and neuroblasts in the adult much more than in the neonate. Less likely is that increases in cell cycle time of forebrain neural progenitors known to occur with age contribute to the differences (Lewis, 1978; Schultze and Korr, 1981; Smith and Luskin, 1998; Calegari et al., 2005) ; however, the degree of cell cycle lengthening in the adult (33% increase in cell cycle duration between P2 and adult) is relatively small and restricted to the G 1 phase and, therefore, is unlikely to account for the large differences we observed between the BrdU labeling index of Sox3-expressing cells in neonatal vs. adult mice. Because of the heterogeneous nature of in situ SVZ and SGZ progenitors and the paucity of reports comparing their cell compositions and cell cycle times at different ages, the complexity precludes definitive conclusions regarding the contribution of cell cycle alterations.
In the adult SVZ and SGZ, newly divided cells are Sox3 positive and turn off Sox3 expression within 2 weeks. Intriguingly, nearly all of the BrdU-labeled cells that persist in the ventral SVZ continue to express Sox3 for at least 14 days after BrdU incorporation. These cells therefore may represent the relatively quiescent neural stem cell population. This idea is supported by the recent finding that quiescent adult SVZ stem cells are located primarily in the ventral aspect of the SVZ (Ahn and Joyner, 2005) . Thus, Sox3 appears to be expressed by more immature, quiescent neural progenitor cells in the neonatal forebrain, but a portion of the Sox3-positive cells in the ventral SVZ of the adult may be stem cells.
Potential Sox3 functions in postnatal neurogenic and nonneurogenic brain regions
Specific roles for Sox3 in development are only beginning to be defined. Studies of Sox3 null mice indicate that it is required for proper formation of the hypothalamicpituitary axis (Rizzoti et al., 2004 ). Sox3-deficient mice also have craniofacial abnormalities and defects in CNS midline structures (Rizzoti et al., 2004) . Our finding that Sox3 is expressed by GFAP-and ␤-tubulin-positive, BrdUlabeled cells in the adult SVZ and SGZ suggests that it may continue to regulate proliferation, survival, or differentiation of neural progenitor cells throughout life. Supporting this idea are recent data indicating that deficiency of the closely related SoxB1 family gene Sox2 leads to decreased BrdU-and GFAP-positive cell numbers in the adult SVZ and SGZ (Ferri et al., 2004) . In addition, we found that Sox3 colocalizes with cells expressing the intermediate filament protein nestin, which is a marker for most neural progenitor cells from embryonic ages to adulthood. Recently, the neural enhancer region of nestin has been found to contain a binding site for Sox B1 proteins (Tanaka et al., 2004) . These findings together suggest that Sox B1 proteins play important roles in maintaining neural progenitors.
Both our anti-Sox3 antibody and the commercial antiSox2 antibody that we used were raised in rabbits, excluding a direct comparison of the two proteins by double labeling. We found, however, that Sox3-and Sox2-immunoreactive cell populations were very similar but did not completely overlap in the adult, with Sox3 found in slightly more differentiated neural progenitors. These similar transcription factors therefore may have subtly different effects on neural progenitor development in the rodent. In chick spinal cord, Sox1-3 maintain neural progenitor cells in an undifferentiated state by counteracting the activity of proneural proteins (Bylund et al., 2003) . Sox3 down-regulation upon neuronal differentiation in adult rodent olfactory bulb and dentate gyrus is consistent with a similar role.
We found that Sox3 also is expressed in certain nonneurogenic regions of the neonatal and adult mouse brain. These areas include the olfactory tubercle, dorsolateral septum, cerebellar Purkinje cell layer, lateral habenular nucleus, and ventromedial hypothalamus. Weaker Sox3 immunoreactivity appears in scattered pyramidal cells of the cerebral cortex and in striatal and thalamic neurons, similar to the pattern recently described for Sox2 (Ferri et al., 2004) . Although some Sox3-immunoreactive cells in nonneurogenic zones may be quiescent or cycling neural progenitors known to exist throughout the brain parenchyma (Palmer et al., 1999; Gensert and Goldman, 2001) , the large numbers and discrete organization suggest that most are mature neurons. Some interneuron-like cells in the hippocampal dentate gyrus also express Sox3, occasionally in a cytoplasmic rather than nuclear pattern. Similar patterns of persistent expression in differentiated neurons and altered cellular localization in the adult have been described for other transcription factors involved in neural development, such as basic helix-loop-helix and homeobox proteins, including Olig1/2 and Otx1; however, specific roles for these proteins in the adult have not been determined (Elliott et al., 2001; Zhang et al., 2002; Samanta and Kessler, 2004) . Experiments to manipulate Sox3 expression at different ages and in specific cell types will no doubt shed light on both developmental and maintenance functions of this protein in the postnatal mammalian brain.
